ホーム › 2型糖尿病 › アラバマ州 › Birmingham
Birmingham、ALにおける2型糖尿病の臨床試験
Birminghamとその周辺地域（約30マイル以内）の拠点で、2型糖尿病に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
被験者募集中
- University of Alabama, Birmingham
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
被験者募集中
- University of Alabama, Birmingham
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
被験者募集中第3相
- Cahaba Research, Inc. - Trussville Location, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
被験者募集中第3相
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
被験者募集中第3相
- AURORA-2 Clinical Site, Birmingham
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
被験者募集中第2相
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
被験者募集中第2相
- Flourish Research, Birmingham
Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
被験者募集中
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
被験者募集中第3相
- Univ of Alabama Birmingham, Birmingham
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Birmingham
CGM for Management of Type 2 Diabetes in Pregnancy
被験者募集中
- University of Alabama at Birmingham, Birmingham
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
被験者募集中第2相
- Central Research Associates, LLC dba Flourish Research, Birmingham
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
被験者募集中観察研究
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
被験者募集中
- The Worship Center Cristian Church, Birmingham
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
被験者募集中
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
他の都市における2型糖尿病の試験
- San Antonio, TX37件の研究
- Houston, TX31件の研究
- Orlando, FL24件の研究
- Boston, MA20件の研究
- Miami, FL19件の研究
- Chicago, IL19件の研究
- Dallas, TX19件の研究
- Columbus, OH18件の研究
- Las Vegas, NV18件の研究
- Atlanta, GA17件の研究
- San Diego, CA17件の研究
- Los Angeles, CA16件の研究
Birminghamにおける他の研究
- がん（全種類）30件の研究
- 乳がん24件の研究
- 肥満症23件の研究
- 卵巣がん23件の研究
- 非小細胞肺癌22件の研究
- 急性骨髄性白血病21件の研究
- 多発性骨髄腫18件の研究
- COPD17件の研究
- 心血管疾患17件の研究
- 過体重16件の研究
- 子宮内膜がん16件の研究
- 嚢胞性線維症16件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。